Uscom Limited (UCM.AX)
AUD 0.03
(0.0%)
AUD 0.03
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -1.5 Million AUD | 40.43% |
| 2023 | -2.53 Million AUD | -15.73% |
| 2022 | -1.84 Million AUD | -111.24% |
| 2021 | -833.83 Thousand AUD | 15.62% |
| 2020 | -672.88 Thousand AUD | -17.57% |
| 2019 | -1.04 Million AUD | 36.57% |
| 2018 | -1.64 Million AUD | -9.39% |
| 2017 | -1.5 Million AUD | 7.33% |
| 2016 | -2.05 Million AUD | -65.14% |
| 2015 | -1.41 Million AUD | 21.31% |
| 2014 | -1.62 Million AUD | 26.22% |
| 2013 | -1.7 Million AUD | 16.53% |
| 2012 | -2.11 Million AUD | 27.4% |
| 2011 | -2.8 Million AUD | -39.41% |
| 2010 | -2.06 Million AUD | -10.6% |
| 2009 | -1.81 Million AUD | 23.13% |
| 2008 | -2.41 Million AUD | 43.47% |
| 2007 | -4.17 Million AUD | -1.77% |
| 2006 | -4.1 Million AUD | -49.06% |
| 2005 | -3.05 Million AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -888.65 Thousand AUD | 0.0% |
| 2024 Q4 | -1.03 Million AUD | 0.0% |
| 2024 FY | - AUD | 21.48% |
| 2023 FY | - AUD | -15.73% |
| 2023 Q4 | -1.15 Million AUD | 0.0% |
| 2023 Q2 | -1.38 Million AUD | 0.0% |
| 2022 Q4 | -1 Million AUD | 0.0% |
| 2022 FY | - AUD | -111.24% |
| 2022 Q2 | -1.18 Million AUD | 0.0% |
| 2021 Q2 | -460.79 Thousand AUD | 0.0% |
| 2021 Q4 | -575.68 Thousand AUD | 0.0% |
| 2021 FY | - AUD | 15.62% |
| 2020 FY | - AUD | -17.57% |
| 2020 Q4 | 219.22 Thousand AUD | 0.0% |
| 2020 Q2 | -1.44 Million AUD | 0.0% |
| 2019 FY | - AUD | 36.57% |
| 2019 Q4 | -821.46 Thousand AUD | 0.0% |
| 2019 Q2 | -594.93 Thousand AUD | 0.0% |
| 2018 Q4 | -711.09 Thousand AUD | 0.0% |
| 2018 FY | - AUD | -9.39% |
| 2018 Q2 | -935.98 Thousand AUD | 0.0% |
| 2017 Q2 | -690.46 Thousand AUD | 0.0% |
| 2017 Q4 | -815.19 Thousand AUD | 0.0% |
| 2017 FY | - AUD | 7.33% |
| 2016 FY | - AUD | -65.14% |
| 2016 Q4 | -907.2 Thousand AUD | 0.0% |
| 2016 Q2 | -717.51 Thousand AUD | 0.0% |
| 2015 FY | - AUD | 21.31% |
| 2015 Q2 | -307.08 Thousand AUD | 0.0% |
| 2015 Q4 | -676.77 Thousand AUD | 0.0% |
| 2014 Q1 | -416.21 Thousand AUD | 49.46% |
| 2014 FY | - AUD | 26.22% |
| 2014 Q4 | -436.9 Thousand AUD | -7.64% |
| 2014 Q3 | -405.88 Thousand AUD | 41.63% |
| 2014 Q2 | -695.29 Thousand AUD | -67.05% |
| 2013 FY | - AUD | 16.53% |
| 2013 Q4 | -823.57 Thousand AUD | -97.87% |
| 2013 Q3 | -416.21 Thousand AUD | 0.0% |
| 2013 Q2 | -416.21 Thousand AUD | 21.74% |
| 2013 Q1 | -531.83 Thousand AUD | 0.0% |
| 2012 Q3 | -531.83 Thousand AUD | 0.0% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 FY | - AUD | 27.4% |
| 2012 Q1 | -731.84 Thousand AUD | 0.0% |
| 2012 Q2 | -531.83 Thousand AUD | 27.33% |
| 2011 Q2 | -731.84 Thousand AUD | -44.7% |
| 2011 Q4 | - AUD | 100.0% |
| 2011 FY | - AUD | -39.41% |
| 2011 Q1 | -505.76 Thousand AUD | 0.0% |
| 2011 Q3 | -731.84 Thousand AUD | 0.0% |
| 2010 FY | - AUD | -10.6% |
| 2010 Q4 | - AUD | 100.0% |
| 2010 Q3 | -505.76 Thousand AUD | 0.0% |
| 2010 Q1 | -380.62 Thousand AUD | 0.0% |
| 2010 Q2 | -505.76 Thousand AUD | -32.88% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | - AUD | 23.13% |
| 2009 Q2 | -380.62 Thousand AUD | 33.33% |
| 2009 Q3 | -380.62 Thousand AUD | 0.0% |
| 2009 Q1 | -570.87 Thousand AUD | 0.0% |
| 2008 Q4 | - AUD | 100.0% |
| 2008 Q3 | -570.87 Thousand AUD | 0.0% |
| 2008 FY | - AUD | 43.47% |
| 2008 Q1 | -827.89 Thousand AUD | 0.0% |
| 2008 Q2 | -570.87 Thousand AUD | 31.05% |
| 2007 Q4 | - AUD | 100.0% |
| 2007 FY | - AUD | -1.77% |
| 2007 Q3 | -827.89 Thousand AUD | 0.0% |
| 2007 Q2 | -827.89 Thousand AUD | 5.49% |
| 2007 Q1 | -875.96 Thousand AUD | 0.0% |
| 2006 FY | - AUD | -49.06% |
| 2006 Q2 | -875.96 Thousand AUD | 33.85% |
| 2006 Q4 | - AUD | 100.0% |
| 2006 Q3 | -875.96 Thousand AUD | 0.0% |
| 2006 Q1 | -1.32 Million AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q2 | -1.32 Million AUD | 0.0% |
| 2005 Q4 | - AUD | 100.0% |
| 2005 Q3 | -1.32 Million AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q2 | - AUD | 0.0% |
| 2003 Q3 | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 95.815% |
| Adherium Limited | -11.56 Million AUD | 86.949% |
| Aroa Biosurgery Limited | -7.36 Million AUD | 79.493% |
| Atomo Diagnostics Limited | -5.42 Million AUD | 72.171% |
| Anteris Technologies Ltd | -66.9 Million AUD | 97.744% |
| Control Bionics Limited | -5.15 Million AUD | 70.74% |
| CardieX Limited | -6.71 Million AUD | 77.513% |
| Compumedics Limited | 2.78 Million AUD | 154.117% |
| Cochlear Limited | 579.5 Million AUD | 100.26% |
| CleanSpace Holdings Limited | -3.49 Million AUD | 56.776% |
| Cyclopharm Limited | -3.03 Million AUD | 50.268% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | 27.826% |
| Nova Eye Medical Limited | -5.97 Million AUD | 74.756% |
| HeraMED Limited | -3.97 Million AUD | 62.002% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 93.099% |
| ImpediMed Limited | -22.05 Million AUD | 93.155% |
| InhaleRx Limited | -1.41 Million AUD | -6.76% |
| LBT Innovations Limited | -4.04 Million AUD | 62.724% |
| Micro-X Limited | -14.35 Million AUD | 89.483% |
| Neurotech International Limited | -8.24 Million AUD | 81.692% |
| OncoSil Medical Limited | -11.97 Million AUD | 87.397% |
| PolyNovo Limited | 5.17 Million AUD | 129.194% |
| Respiri Limited | -7.04 Million AUD | 78.591% |
| SomnoMed Limited | -2.32 Million AUD | 35.184% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 83.397% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | 69.307% |